Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database

导出原文传递

翻译打印收藏纠错

作者： Fujioka, Isao ^[1] ; Takaku, Tomoiku ^[2] ; Iriyama, Noriyoshi ^[3] ; Tokuhira, Michihide ^[4] ; Kimura, Yuta ^[5] ; Sato, Eriko ^[6] ; Ishikawa, Maho ^[7] ; Nakazato, Tomonori ^[8] ; Sugimoto, Kei-Ji ^[9] ; Fujita, Hiroyuki ; Asou, Norio ; Kizaki, Masahiro ; Hatta, Yoshihiro ; Komatsu, Norio ; Kawaguchi, Tatsuya

作者单位： Kumamoto Univ Hosp, Dept Hematol & Infect Dis, Kumamoto, Japan ^[1] Yokohama Municipal Citizens Hosp, Dept Hematol, Yokohama, Kanagawa, Japan ^[2] Juntendo Univ, Nerima Hosp, Dept Hematol, Tokyo, Japan ^[3] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Saitama, Japan ^[4] Saiseikai Yokohama Nanbu Hosp, Dept Hematol, Yokohama, Kanagawa, Japan ^[5] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo, Japan ^[6] Juntendo Univ, Sch Med, Dept Hematol, Bunkyo Ku, 3-1-1 Hongo, Tokyo 1130033, Japan ^[7] Saitama Med Univ, Int Med Ctr, Comprehens Canc Ctr, Dept Hematooncol, Saitama, Japan ^[8] Juntendo Univ, Urayasu Hosp, Dept Hematol, Urayasu, Japan ^[9]

关键词 Cardiovascular disease Tyrosine kinase inhibitor Chronic myeloid leukemia Vascular adverse events Japanese patients

发布时间 2019-04-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交